Five consecutive years of flat funding for the National Institutes
of Health (NIH) is deterring promising young researchers and taking a
severe toll on American medical research, according to a new report by
seven major academic research institutions.
The report, “A Broken Pipeline? Flat Funding of the NIH Puts a
Generation of Science at Risk,” documents the toll and profiles junior
researchers from institutions across the country who are facing funding
“Right now, the nation’s brightest young researchers, upon whom the
future of American medicine rests, are getting the message that
biomedical research may be a dead end and they should explore other
career options—and in too many cases, they’re taking that message to
heart,” said Drew Faust, PhD, president of Harvard University.
The report focuses particularly on the effect on young researchers,
who are getting a much smaller piece of the NIH pie. However, the
report notes that “competition for limited resources is affecting
scientists at every point of the academic research pipeline.”
Between 1998 and 2003, the Clinton and Bush administrations and
Congress doubled the NIH budget—fueling such innovative projects as the
completion of the human genome project and the creation of powerful new
tools that create a window into biological systems. Everything changed
in 2003, when the budget increases stopped. Since that time, NIH’s
budget has experienced a 13 percent drop in real purchasing power—a
drop opposed by IDSA and other supporters of biomedical research.
Today, only one in ten grants is funded upon first submission.
Rejected grants must be resubmitted, which clogs the system and results
in a queue in which young researchers feel they are “at the back of the
“The feedback I received from one reviewer was that my ideas were
‘very innovative and had the potential to make a big impact, but they
were too risky,’” said Tricia Serio, PhD, an assistant professor at
Brown University whose research is focused on Creutzfeldt-Jakob and
other progressive brain diseases. Her point was echoed by other young
researchers who said they have stepped away from riskier research.
Their fears are well founded. The overall success rate for NIH
research project grants dropped from 32 percent in 1999 to 24 percent
in 2007. Only about one in four original research applications is being
funded, and many of those are only partially funded.
The report was co-authored by Brown University, Duke University,
Harvard University, the Ohio State University, Partners Healthcare, the
University of California Los Angeles, and Vanderbilt University. It and
a companion report, “Within Our Grasp—Or Slipping Away? Assuring a New
Era of Scientific and Medical Progress,” are available online at www.brokenpipeline.org.
< Previous Article | Next Article >